These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34038714)

  • 1. Comparison of the drug-drug interactions potential of ibrutinib and acalabrutinib via inhibition of UDP-glucuronosyltransferase.
    Wang X; Wang Z; Fan X; Yan M; Jiang L; Xia Y; Cao J; Liu Y
    Toxicol Appl Pharmacol; 2021 Aug; 424():115595. PubMed ID: 34038714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.
    Korprasertthaworn P; Chau N; Nair PC; Rowland A; Miners JO
    Biochem Pharmacol; 2019 Nov; 169():113616. PubMed ID: 31445021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human UDP-glucuronosyltransferase enzymes by midostaurin and ruxolitinib: implications for drug-drug interactions.
    Wang Z; Wang X; Jia Y; Yin H; Feng Y; Jiang L; Cao J; Liu Y
    Biopharm Drug Dispos; 2020 Jun; 41(6):231-238. PubMed ID: 32436276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human UDP-glucuronosyltransferase enzyme by ripretinib: Implications for drug-drug interactions.
    Lv X; Wang Z; Wang Z; Yin H; Xia Y; Jiang L; Liu Y
    Toxicol Appl Pharmacol; 2023 May; 466():116490. PubMed ID: 36963523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabozantinib Carries the Risk of Drug-Drug Interactions
    Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
    Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: Prediction of in vivo drug-drug interactions.
    Xiao S; Yin H; Lv X; Wang Z; Jiang L; Xia Y; Liu Y
    Chem Biol Interact; 2024 Nov; 403():111246. PubMed ID: 39278459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
    Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
    Zhang N; Liu Y; Jeong H
    Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus-inhibited multiple isoforms of UDP-glucuronosyltransferases (UGTs).
    Du Z; Wang G; Cao YF; Hu CM; Yang K; Liu YZ; Zhang CZ; Zhang WH; Zhu ZT; Sun HZ; Sun XY; Hong M; Fang ZZ
    Xenobiotica; 2018 May; 48(5):452-458. PubMed ID: 28548030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and management.
    Fancher KM; Pappacena JJ
    Cancer Chemother Pharmacol; 2020 Oct; 86(4):507-515. PubMed ID: 32940733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human UDP-glucuronosyltransferase enzyme by Dabrafenib: Implications for drug-drug interactions.
    Yin H; Wang Z; Wang X; Lv X; Fan X; Yan M; Jia Y; Jiang L; Cao J; Liu Y
    Biomed Chromatogr; 2021 Nov; 35(11):e5205. PubMed ID: 34192355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibition of human UDP-glucuronosyltransferase (UGT) 1A1 by osimertinib, and prediction of in vivo drug-drug interactions.
    Wang Z; Wang X; Wang Z; Jia Y; Feng Y; Jiang L; Xia Y; Cao J; Liu Y
    Toxicol Lett; 2021 Sep; 348():10-17. PubMed ID: 34044055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events of Bruton's tyrosine kinase inhibitors: A real-world study based on the United States Food and Drug Administration Adverse Event Reporting System database.
    Zhao ZX; Yang TY; Wang YH; Zhang L; Li J; Su YW
    Br J Clin Pharmacol; 2024 Sep; 90(9):2166-2179. PubMed ID: 38831641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
    Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
    Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human UDP-glucuronosyltransferase enzyme by belinostat: Implications for drug-drug interactions.
    Wang X; Wang Z; Wang Z; Chen X; Yin H; Jiang L; Cao J; Liu Y
    Toxicol Lett; 2021 Mar; 338():51-57. PubMed ID: 33290829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong inhibition of deoxyschizandrin and schisantherin A toward UDP-glucuronosyltransferase (UGT) 1A3 indicating UGT inhibition-based herb–drug interaction.
    Liu C; Cao YF; Fang ZZ; Zhang YY; Hu CM; Sun XY; Huang T; Zeng J; Fan XR; Mo H
    Fitoterapia; 2012 Dec; 83(8):1415-9. PubMed ID: 23339253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human UDP-glucuronosyltransferase enzyme by entrectinib: Implications for drug-drug interactions.
    Yin H; Wang Z; Lv X; Wang Z; Wang Y; Fan W; Li S; Jiang L; Cao J; Liu Y
    Chem Biol Interact; 2024 May; 395():111023. PubMed ID: 38677539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Comparative Study of the Inhibitory Effects of Mangiferin and Its Aglycone Norathyriol towards UDP-Glucuronosyl Transferase (UGT) Isoforms.
    Sun D; Zhang CZ; Ran RX; Cao YF; Du Z; Fu ZW; Huang CT; Zhao ZY; Zhang WH; Fang ZZ
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28621744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice.
    O'Riordan CE; Purvis GSD; Collotta D; Chiazza F; Wissuwa B; Al Zoubi S; Stiehler L; Martin L; Coldewey SM; Collino M; Thiemermann C
    Front Immunol; 2019; 10():2129. PubMed ID: 31552054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the inhibition potential of parthenolide and micheliolide on various UDP-glucuronosyltransferase isoforms.
    Gao WF; Li YX; Zhang WH; Tao R; Yin TT; Wang YJ; Liu LN; Fu ZW; Li SN; Liu NR; Zhang H; Liu G; Zhao LZ; Zhang XP; Zhang CZ
    Xenobiotica; 2019 Oct; 49(10):1158-1163. PubMed ID: 30484368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.